Axsome Therapeutics, Inc. (AXSM)
183.70
-2.48
(-1.33%)
USD |
NASDAQ |
Feb 20, 16:00
183.96
+0.26
(+0.14%)
After-Hours: 20:00
Axsome Therapeutics Market Cap : 9.261B for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 3.669B |
| Gilead Sciences, Inc. | 187.86B |
| Vanda Pharmaceuticals, Inc. | 340.46M |
| ACADIA Pharmaceuticals, Inc. | 4.060B |
| Amicus Therapeutics, Inc. | 4.502B |
Market Cap Related Metrics
| PS Ratio | 16.11 |
| Price to Book Value | 125.61 |
| Price | 183.70 |
| Earnings Yield | -2.54% |